• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群在肥胖和慢性应激条件下对心血管系统的影响。

The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress.

机构信息

Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Banacha 1b, 02-097, Warsaw, Poland.

出版信息

Curr Hypertens Rep. 2021 May 20;23(5):31. doi: 10.1007/s11906-021-01144-7.

DOI:10.1007/s11906-021-01144-7
PMID:34014393
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8137478/
Abstract

PURPOSE OF REVIEW

Based on the available data, it can be assumed that microbiota is an integral part of the human body. The most heavily colonized area of the human body is the gut, with bacterial accumulation ranging from 10-10 cells/g in the upper intestine to 10-10 cells/g in the colon. However, colonization of the gut is not the same throughout, as it was shown that there are differences between the composition of the microbiota in the intestine lumen and in the proximity of the mucus layer.

RECENT FINDINGS

Gut microbiota gradient can be differentially regulated by factors such as obesity and chronic stress. In particular, a high fat diet influences the gut microbial composition. It was also found that chronic stress may cause the development of obesity and thus change the organization of the intestinal barrier. Recent research has shown the significant effect of intestinal microflora on cardiovascular function. Enhanced absorption of bacterial fragments, such as lipopolysaccharide (LPS), promotes the onset of "metabolic endotoxemia," which could activate toll-like receptors, which mediates an inflammatory response and in severe cases could cause cardiovascular diseases. It is presumed that the intestinal microbiota, and especially its metabolites (LPS and trimethylamine N-oxide (TMAO)), may play an important role in the pathogenesis of arterial hypertension, atherosclerosis, and heart failure. This review focuses on how gut microbiota can change the morphological and functional activity of the cardiovascular system in the course of obesity and in conditions of chronic stress.

摘要

目的综述

根据现有数据,可以假设微生物群是人体的一个组成部分。人体中细菌定植最严重的区域是肠道,在上消化道中细菌积累量为 10-10 个细胞/g,在结肠中为 10-10 个细胞/g。然而,肠道的定植并不完全相同,因为已经表明肠道腔和黏液层附近的微生物群落组成存在差异。

最新发现

肥胖和慢性应激等因素可以调节肠道微生物群的梯度。特别是高脂肪饮食会影响肠道微生物组成。此外,研究还发现慢性应激可能导致肥胖的发展,从而改变肠道屏障的结构。最近的研究表明,肠道微生物群对心血管功能有显著影响。细菌片段(如脂多糖[LPS])的吸收增强会促进“代谢性内毒素血症”的发生,从而激活 Toll 样受体,介导炎症反应,在严重的情况下会导致心血管疾病。据推测,肠道微生物群及其代谢产物(LPS 和三甲胺 N-氧化物[TMAO])可能在动脉高血压、动脉粥样硬化和心力衰竭的发病机制中起重要作用。本综述重点讨论了肠道微生物群如何在肥胖过程中和慢性应激条件下改变心血管系统的形态和功能活动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00b0/8137478/007ebf2ef0c6/11906_2021_1144_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00b0/8137478/007ebf2ef0c6/11906_2021_1144_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00b0/8137478/007ebf2ef0c6/11906_2021_1144_Fig1_HTML.jpg

相似文献

1
The Influence of Gut Microbiota on the Cardiovascular System Under Conditions of Obesity and Chronic Stress.肠道微生物群在肥胖和慢性应激条件下对心血管系统的影响。
Curr Hypertens Rep. 2021 May 20;23(5):31. doi: 10.1007/s11906-021-01144-7.
2
Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.肠道微生物群介导膳食辣椒素对高脂饮食诱导的慢性低度炎症和相关肥胖的保护作用。
mBio. 2017 May 23;8(3):e00470-17. doi: 10.1128/mBio.00470-17.
3
Gut Microbiota in Cardiovascular Health and Disease.肠道微生物群与心血管健康和疾病
Circ Res. 2017 Mar 31;120(7):1183-1196. doi: 10.1161/CIRCRESAHA.117.309715.
4
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.肠道微生物群组成可调节饮食中胆碱的生物利用度以及促动脉粥样硬化代谢物氧化三甲胺的积累。
mBio. 2015 Mar 17;6(2):e02481. doi: 10.1128/mBio.02481-14.
5
High-fat diet intake modulates maternal intestinal adaptations to pregnancy and results in placental hypoxia, as well as altered fetal gut barrier proteins and immune markers.高脂肪饮食摄入会调节母体肠道对妊娠的适应性,导致胎盘缺氧,以及胎儿肠道屏障蛋白和免疫标志物的改变。
J Physiol. 2019 Jun;597(12):3029-3051. doi: 10.1113/JP277353. Epub 2019 May 13.
6
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.肠道微生物群(微生物组)与心血管疾病及其治疗调节。
Front Cell Infect Microbiol. 2022 Jun 20;12:903570. doi: 10.3389/fcimb.2022.903570. eCollection 2022.
7
Role of Gut Microbiota and Their Metabolites on Atherosclerosis, Hypertension and Human Blood Platelet Function: A Review.肠道微生物群及其代谢产物在动脉粥样硬化、高血压和人类血小板功能中的作用:综述。
Nutrients. 2021 Jan 3;13(1):144. doi: 10.3390/nu13010144.
8
The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.肠道菌群失调在心力衰竭的心血代谢危险因素中的新作用。
Curr Hypertens Rep. 2020 May 8;22(5):38. doi: 10.1007/s11906-020-01046-0.
9
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.肠道微生物组与冠状动脉疾病和心力衰竭:现有知识和未来方向。
EBioMedicine. 2020 Feb;52:102649. doi: 10.1016/j.ebiom.2020.102649. Epub 2020 Feb 12.
10
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion.低聚果糖通过改变肠道微生物群、肠黏液产生、糖基化和分泌来预防高脂肪饮食诱导的肥胖。
Gut Microbes. 2022 Jan-Dec;14(1):2152307. doi: 10.1080/19490976.2022.2152307.

引用本文的文献

1
Exploring the Prevention of Lipid Deposition Caused by High-Fat Diet and Its Mechanism of Action of Fermented Juice Based on Liver Metabolomics and Gut Microbiota.基于肝脏代谢组学和肠道微生物群探究发酵汁对高脂饮食引起的脂质沉积的预防作用及其作用机制
Food Sci Nutr. 2025 Jul 28;13(8):e70449. doi: 10.1002/fsn3.70449. eCollection 2025 Aug.
2
Gut over Mind: Exploring the Powerful Gut-Brain Axis.肠道胜过大脑:探索强大的肠脑轴
Nutrients. 2025 Feb 28;17(5):842. doi: 10.3390/nu17050842.
3
Risk factors and prognostic value of endotoxemia in patients with acute myocardial infarction.

本文引用的文献

1
Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension.肠道微生物衍生的短链脂肪酸促进微生物群-宿主相互作用并调节肥胖和高血压。
Curr Hypertens Rep. 2021 Feb 3;23(2):8. doi: 10.1007/s11906-020-01125-2.
2
They eat, what we eat, they digest, what we ingest: the microbiome and the vulnerable plaque.它们吃我们所吃的,消化我们摄取的:微生物群与易损斑块。
Cardiovasc Res. 2021 Jan 21;117(2):333-335. doi: 10.1093/cvr/cvaa339.
3
The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.
急性心肌梗死患者内毒素血症的危险因素及预后价值
Front Cardiovasc Med. 2024 Jun 25;11:1419001. doi: 10.3389/fcvm.2024.1419001. eCollection 2024.
4
The Mediterranean Diet, Its Microbiome Connections, and Cardiovascular Health: A Narrative Review.地中海饮食、其微生物组关联与心血管健康:叙事性综述。
Int J Mol Sci. 2024 Apr 30;25(9):4942. doi: 10.3390/ijms25094942.
5
Connections between serum Trimethylamine N-Oxide (TMAO), a gut-derived metabolite, and vascular biomarkers evaluating arterial stiffness and subclinical atherosclerosis in children with obesity.血清三甲胺 N-氧化物(TMAO)与血管生物标志物之间的关系,TMAO 是一种肠道衍生代谢物,可评估肥胖儿童的动脉僵硬度和亚临床动脉粥样硬化。
Front Endocrinol (Lausanne). 2023 Oct 2;14:1253584. doi: 10.3389/fendo.2023.1253584. eCollection 2023.
6
The sex-dependent response to psychosocial stress and ischaemic heart disease.对心理社会压力和缺血性心脏病的性别依赖性反应。
Front Cardiovasc Med. 2023 Apr 21;10:1072042. doi: 10.3389/fcvm.2023.1072042. eCollection 2023.
7
Communication of gut microbiota and brain immune and neuroendocrine signaling.肠道微生物群与大脑免疫及神经内分泌信号传导之间的交流。
Front Microbiol. 2023 Jan 25;14:1118529. doi: 10.3389/fmicb.2023.1118529. eCollection 2023.
8
Role of Gut Microbiome in Cardiovascular Events: A Systematic Review.肠道微生物群在心血管事件中的作用:一项系统评价
Cureus. 2022 Dec 13;14(12):e32465. doi: 10.7759/cureus.32465. eCollection 2022 Dec.
9
Toll-like receptor 4-mediated endoplasmic reticulum stress induces intestinal paneth cell damage in mice following CLP-induced sepsis.Toll 样受体 4 介导线粒体应激诱导 CLP 诱导的脓毒症小鼠肠道潘氏细胞损伤。
Sci Rep. 2022 Sep 10;12(1):15256. doi: 10.1038/s41598-022-19614-6.
10
Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota.奥利司他和依泽替米贝可通过调节肠道微生物群以不同方式减轻高脂饮食诱导的肥胖表型。
Front Microbiol. 2022 Aug 15;13:908327. doi: 10.3389/fmicb.2022.908327. eCollection 2022.
肠道菌群失调在心力衰竭的心血代谢危险因素中的新作用。
Curr Hypertens Rep. 2020 May 8;22(5):38. doi: 10.1007/s11906-020-01046-0.
4
Towards a psychobiotic therapy for depression: CCFM1025 reverses chronic stress-induced depressive symptoms and gut microbial abnormalities in mice.迈向抑郁症的精神益生菌疗法:CCFM1025可逆转慢性应激诱导的小鼠抑郁症状和肠道微生物异常。
Neurobiol Stress. 2020 Mar 20;12:100216. doi: 10.1016/j.ynstr.2020.100216. eCollection 2020 May.
5
Gut microbiota: a promising target against cardiometabolic diseases.肠道微生物群:对抗心血管代谢疾病的有前途的靶点。
Expert Rev Endocrinol Metab. 2020 Jan;15(1):13-27. doi: 10.1080/17446651.2020.1720511.
6
The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.肠道微生物组与冠状动脉疾病和心力衰竭:现有知识和未来方向。
EBioMedicine. 2020 Feb;52:102649. doi: 10.1016/j.ebiom.2020.102649. Epub 2020 Feb 12.
7
Gut microbiome of a porcine model of metabolic syndrome and HF-pEF.代谢综合征和 HF-pEF 猪模型的肠道微生物组。
Am J Physiol Heart Circ Physiol. 2020 Mar 1;318(3):H590-H603. doi: 10.1152/ajpheart.00512.2019. Epub 2020 Feb 7.
8
The progress of gut microbiome research related to brain disorders.肠道微生物组与脑疾病相关研究进展。
J Neuroinflammation. 2020 Jan 17;17(1):25. doi: 10.1186/s12974-020-1705-z.
9
Stress, Dietary Patterns and Cardiovascular Disease: A Mini-Review.压力、饮食模式与心血管疾病:一篇综述短文
Front Neurosci. 2019 Nov 12;13:1226. doi: 10.3389/fnins.2019.01226. eCollection 2019.
10
Gut Microbiota and Obesity: A Role for Probiotics.肠道微生物群与肥胖:益生菌的作用。
Nutrients. 2019 Nov 7;11(11):2690. doi: 10.3390/nu11112690.